SYNERGISTIC TARGETING OF ANDROGEN RECEPTOR AND NONRECEPTOR TYROSINE KINASE BMX

$130,500FY2014Department of DefenseDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators